Status:
RECRUITING
The Relationship Between Child Language Proficiency and Language of Treatment on the Outcomes of Bilingual Children with Developmental Language Disorder
Lead Sponsor:
University of Houston
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
University of Delaware
Conditions:
Developmental Language Disorder
Language Impairment
Eligibility:
All Genders
4-6 years
Phase:
NA
Brief Summary
Of the 12 million children in the USA growing up bilingual, about 1 million experience Developmental Language Disorder (DLD), a disorder in language learning and use. Currently there is no guidance fo...
Detailed Description
More than 8.5 million children in the USA speak Spanish at home with about a half million experiencing Developmental Language Disorder (DLD), a disorder in language learning and use that cannot be att...
Eligibility Criteria
Inclusion
- parent concerns and/or a history of receiving services in the public schools
- age-specific cutoffs for the morphosyntax subtests for their best language (English or Spanish) on the Bilingual English Spanish Assessment. The cut-off score for best language for 4-year-olds is 84, for 5-year-olds is 85, and for 6-year-olds is 81. Using the best-language approach, these scores have a sensitivity over 90% and specificity over 80% for children between 4;0 and 6;11 years of age , which is considered acceptable for studies of diagnostic accuracy.
- nonverbal IQ, as measured by the Kaufman Brief Intelligence Test-2, matrices subtest, will be at or above a standard score of 70.
- pass a hearing screening test
- participants must be bilingual, that is children must be producing at least simple sentences in spontaneous speech in both Spanish and English, or understand English and Spanish.
- participants must be able to benefit from treatment for both conditional adverbial clauses and complement clauses, as evidenced by accuracy below 40% on 10-item elicited production probes in both languages
Exclusion
- 1\) children with significant sensory-motor concerns or psychiatric disorders per parent report will not be enrolled.
Key Trial Info
Start Date :
August 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2028
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06085300
Start Date
August 8 2023
End Date
May 1 2028
Last Update
January 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School Districst
Houston, Texas, United States, 77204